The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 22, 2010

Filed:

Jun. 29, 2005
Applicants:

Srinivasan Ramanathan, Mountain View, CA (US);

Stanley Stein, East Brunswick, NJ (US);

Michael Leibowitz, Manalapan, NJ (US);

Patrick J. Sinko, Lebanon, NJ (US);

Tamara Minko, Edison, NJ (US);

Gregory C. Williams, Warren, NJ (US);

Goubao Zhang, San Diego, CA (US);

Xiaoping Zhang, Piscataway, NJ (US);

Shahrair Pooyan, Monnt Kisco, NY (US);

Seong Hee Park, Piscataway, NJ (US);

BO Qiu, East Brunswick, NJ (US);

Pankaj Paranjpe, Piscataway, NJ (US);

Inventors:

Srinivasan Ramanathan, Mountain View, CA (US);

Stanley Stein, East Brunswick, NJ (US);

Michael Leibowitz, Manalapan, NJ (US);

Patrick J. Sinko, Lebanon, NJ (US);

Tamara Minko, Edison, NJ (US);

Gregory C. Williams, Warren, NJ (US);

Goubao Zhang, San Diego, CA (US);

Xiaoping Zhang, Piscataway, NJ (US);

Shahrair Pooyan, Monnt Kisco, NY (US);

Seong Hee Park, Piscataway, NJ (US);

Bo Qiu, East Brunswick, NJ (US);

Pankaj Paranjpe, Piscataway, NJ (US);

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 38/04 (2006.01); A61K 38/00 (2006.01); A61K 51/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention is directed to pharmaceutical compositions and methods for delivery of a therapeutic or diagnostic agent from one bodily compartment to one or more other bodily compartment by administering one of the following conjugates: a polymer having multiple functional groups at least one of which is covalently bound to a therapeutic or diagnostic agent, and at least one cell uptake promoter covalently bound to the therapeutic or diagnostic agent; or a polymer and at least one cell uptake promoter bound thereto; the polymer further comprising multiple functional groups at least one of which is covalently bound a therapeutic or diagnostic agent.


Find Patent Forward Citations

Loading…